12/20/2023 0 Comments Timi risk score![]() The patients were evaluated in groups of two, namely MACE (+) and MACE (-), and also as "High" and "Low" according to the cut-off value of the MPVLR + TIMI modified score., Results: The area under the curve values of the modified MPVLR + TIMI for two-year MACE and mortality prediction were found to be 0.893 (0.812-0.974, p < 0.001) and 0.864 (0.715-1.00, p = 0.001), respectively, and were observed to be superior to the individual MPVLR and TIMI scores. Hence, we aimed to investigate the relationship between the modified risk score obtained by the combination of TIMI risk score and MPVLR with 2-year-long MACE and mortality in ACS patients., Method: In this study, 472 consecutive patients with a diagnosis of ACS, who were revascularized using percutaneous coronary intervention, were included. However, the prognostic value of a modified score system that is based on the relationships and combinations of these parameters in ACS patients is unknown. Cor et Vasa 2021, 63(6):652-660 | DOI: 10.33678/cor.2021.095 Prognostic value of the combination of TIMI risk score and mean platelet volume to lymphocyte count ratio in patients with acute coronary syndrome Emre Yilmaz a, Ercan Aydin b aĭepartment of Cardiology, Giresun University Faculty of Medicine, Turkey bĭepartment of Cardiology, Vakfikebir State Hospital, Trabzon, Turkeyīackground: Thrombolysis In Myocardial Infarction (TIMI) risk score and MPV/lymphocyte ratio (MPVLR) are important parameters that can be used to predict mortality and major cardiovascular adverse events (MACE) in patients with acute coronary syndrome (ACS). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |